National study: Health Systems Lose $3.1 Billion In Physical Therapy Revenue

Health systems lose an estimated $3.1 billion revenue from physical therapy referral leakage across the 3.9 million commercially insured patients studied in a new national report by Luna, the leading provider of in-home, in-person physical therapy.

In the report based on 2022 national data, 60% of patients referred to physical therapy by their health system opted for a local clinic provider, equating to a loss of $2,000-$3,000 per patient.

physical therapy revenue

Patient preference plays a significant role in referral leakage as many choose to seek care elsewhere based on convenience and geographic reach. For instance, many patients are unwilling to travel more than 2-3 miles to receive healthcare. The limited service availability within health systems also forces some patients to seek more accessible providers closer to their homes.

With over 38,000 clinics nationwide, patients have ample choice when it comes to physical therapy. This superior geographic coverage can serve patients closer to where they live, which creates significant competitive cannibalization on health systems.

“Referral leakage is deeply worrying for health systems, and investing in costly additional locations is not the answer. Health systems need to find creative, innovative solutions to survive, post-pandemic. Offering outpatient physical therapy direct to a patient’s home is a truly advantageous strategy. It expands patient access and geographic coverage, enhances patient satisfaction, and standardizes patient care,” said Palak Shah, co-founder and head of clinical services at Luna.

Leading health systems such as Providence, Emory Healthcare, Intermountain Healthcare, UCLA Health and Scripps Health have partnered with Luna to offer outpatient physical therapy in the convenience of a patient’s home.

Luna currently operates across 50 markets in 27 states and has treated almost 40,000 patients in their homes.

Unlike remote or virtual care, Luna’s licensed physical therapists provide 1:1 hands-on care in the convenience of the patient’s home. Through Luna, patients can request an in-home physical therapy via the company’s app. A licensed physical therapist is then scheduled to arrive at the patient’s home within one hour for a full 45-55 minute appointment.

In 2022, Luna became the fastest growing physical therapy clinic nationally with 6,183 percent growth in visits during the four consecutive years since it was founded in 2018. This is higher than any reported growth during the same time frame from any physical therapy clinic.

Luna has maintained its approach to high-quality care during this record period of growth with a three year running world-class NPS rating, specifically 87 in 2022. According to a recent McKinsey report, up to $265 billion worth of care services, representing up to 25 percent of the total cost of care, is expected to shift to the home by 2025.

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version